Prognostic Forecasting is measured using items [ 5] assessing patients' beliefs about their chances of living two years and chances of being cured.
Using measures adapted from patient versions, caregivers also provide informant ratings of Patient Treatment Preferences, Patient Illness Acceptance, and Patient Well- being, and complete a measure of Prognostic Forecasting.
Several measures have been adapted from the patient self-report surveys: physician beliefs about Patient Treatment Preferences, physician beliefs about Patient Illness Acceptance, and Prognostic Forecasting about patients' prognoses (e.g., chances of a cure, chances of living two years, patients' understanding thereof).
UBD may contribute to the progression of colon carcinogenesis and function as a novel prognostic indicator of forecasting recurrence of stage II and III patients after curative operations.
The modelling system is based on prognostic downscaling of weather forecasts and on multi-scale chemical transport model simulation, in order to describe atmospheric circulation in a complex topographic environment, space/time variation of emissions and pollutant import from neighbouring regions.
Medicine and weather forecast are mature prognostics applications that already proved its applicability.
The prognostic parameters estimated for the forecasts of the neural networks were characterised by lower errors of prediction for both the daily yields and test-day data and exhibited higher coefficients of correlation between the predicted and the actual data (or the yields produced by SYMLEK).
SurvNet may also provide data to identify prognostic criteria that would help in forecasting the natural development of a specific outbreak (25 – 25 ).
When using the model to forecast on the basis of prognostic factors only, predicted 5-year recurrence-free survival was 54.0%, and the resulting calibration score 75%.
These data support UBD as a novel prognostic indicator of colon cancer outcomes, in particular for forecasting recurrence in patients with stage II and III disease following curative surgery.
